Form 4: DocuSign CEO Allan Thygesen Sells Shares Under 10b5-1 Plan

DocuSign's CEO, Allan C. Thygesen, executed multiple sales of common stock on April 1, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On April 1, 2025, Allan C. Thygesen, the President and CEO of DocuSign, sold shares of DocuSign common stock.
• The sales were executed under a Rule 10b5-1 trading plan.
• A total of 40,000 shares were sold in multiple transactions at varying prices.
• The prices ranged from $79.86 to $82.91 per share.
• Following the reported transactions, Thygesen directly owns 138,804 shares of DocuSign common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document reports routine stock sales under a pre-arranged plan, with no explicit positive or negative implications for the company's performance.

Risks

• Executive stock sales can sometimes be perceived negatively by investors, potentially impacting the stock price, although sales under 10b5-1 plans are generally viewed as less concerning.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. Sales under 10b5-1 plans are typically pre-scheduled and less indicative of immediate sentiment.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders due to the potential for short-term price fluctuations, but the existence of a 10b5-1 plan mitigates concerns about insider information.

Key Dates

Keywords

DocuSign, DOCU, Allan Thygesen, CEO, stock sale, Form 4, Rule 10b5-1 plan, executive compensation, insider trading